Skip to main content

Table 1 Patients demographics and clinicopathological characteristics

From: A survival comparison of gastric mucin-producing adenocarcinoma to conventional adenocarcinoma: a SEER database analysis

Variables

n

MPA

n (%)

CA

n (%)

P

Age

  < 60

1996

692 (45.7)

1304 (31.2)

0.00

  ≥ 60

3693

823 (54.3)

2870 (68.8)

 

Gender

 Female

1614

603 (39.8)

1011 (24.2)

0.00

 Male

4075

912 (60.2)

3163 (75.8)

 

Race

 White

4332

1056 (69.7)

3276 (78.5)

0.00

 Black

593

192 (12.7)

401 (9.6)

 

 Others

764

267 (17.6)

497 (11.9)

 

Differentiation

 Well/ Moderate

1885

121 (8)

1764 (42.3)

0.00

 Poor/undifferentiated

3804

1394 (92)

2410 (57.7)

 

Clinical stage

 I

1764

401 (26.5)

1363 (32.7)

0.00

 II

2032

495 (32.7)

1537 (36.8)

 

 III

1893

619 (40.8)

1274 (30.5)

 

T stage

 T1

877

193 (12.7)

684 (16.4)

0.00

 T2

3089

799 (52.8)

2290 (54.9)

 

 T3

1564

473 (31.2)

1091 (26.1)

 

 T4

159

50 (3.3)

109 (2.6)

 

N stage

 N0

1924

462 (30.5)

1462 (35)

0.00

 N1

2861

707 (46.7)

2154 (51.6)

 

 N2

904

346 (22.8)

558 (13.4)

 

Surgery

 Yes

4123

1241 (81.9)

2882 (69.1)

0.00

 No

1566

274 (18.1)

1292 (30.9)

 

Chemotherapy

 Yes

5101

1392 (91.9)

3709 (88.9)

0.001

 No/ unkown

588

123 (8.1)

465 (11.1)

 

Radiotherapy

 Yes

5533

1472 (97.2)

4061 (92.3)

0.78

 No

156

43 (2.8)

113 (7.7)